Clinical Trial Update: Bladder Overactivity and Post-Botulinum Toxin Telemonitoring [NA]

View source ↗

Summary

This clinical trial update from University Hospital, Grenoble investigates telemonitoring after botulinum toxin treatment for overactive bladder. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Overactive Bladder | NA | Status: NOT_YET_RECRUITING